IFITM3 and COVID-19: To do so, we aimed to identify significantly enriched IFN-I signatures and genes along the transolfactory route employing published datasets of the nasal mucosa and olfactory bulb amygdala transcriptomes of COVID-19 patients and determine the presence of IFITM3 specifically in those gene networks.